Certificate of Advanced Studies in Lymphoma

Certificate of Advanced Studies in Lymphoma

CAS LYM banner
Course Overview

The Certificate of Advanced Studies in Lymphoma (CAS-L) was launched in 2013 as the first academic programme dedicated to enhancing both the clinical and scientific competencies of oncology professionals working in lymphoma care.

This part-time, 15-month programme combines four online modules with three in-person seminars, including participation in prestigious international events such as ICML, Learning to Care, and LyFE.

Upon successful completion of the course and final exam, participants will receive an academic certificate jointly awarded by the European School of Oncology (ESO) and the Università della Svizzera italiana (USI).

Programme Details
  • Duration: 15 months
  • Structure: 4 online modules + 3 in-person seminars
  • Seminar 1: ICML 2025, Lugano
  • Seminar 2: ESO Learning to Care Seminar, Padova
  • Seminar 3: LyFE 2027, Bellinzona
  • Collaborating University: Università della Svizzera italiana (USI)
  • Chairs: Emanuele Zucca (CH), Elias Campo (ES), Stephan Stilgenbauer (DE)

ESO College Membership

Participation in this programme grants eligibility to enrol in ESO College.

Members who complete the course and pass the final exam will earn 400 ESCO credits, unlocking access to further educational and career benefits.

Visit ESO College dedicated section for more information on membership and benefits.

Key Dates
  • Applications open: 1 September 2024
  • Application deadline: 30 November 2024
  • Admission notifications: by end of January 2025
  • Seminar 1: 17–21 June 2025 – ICML, Lugano (Switzerland)
  • Seminar 2: 1–5 February 2026 – Learning to Care, Padova (Italy)
  • Seminar 3 + Final Exam: 20-24 January 2027 – Lymphona Forum of Excellence (LyFE), Bellinzona (Switzerland)
Contacts

Sarah Ortelli - sortelli@eso.net

CAS-LYM curriculum overview
Admission
Admission is via competitive application only. A maximum of 25 participants per cohort will be selected. Applications must be submitted with all required documentation before the published deadline.
Attendance
Attendance at all seminars and modules is mandatory in order to be eligible for the final certificate.
Insurance
Participants must arrange their own personal and travel insurance. ESO accepts no liability for events related to seminar attendance.
Eligibility Criteria
This programme is open to:
  • Medical doctors with a master’s degree or equivalent, and at least 2 years’ residency in a relevant oncology setting
  • Natural scientists with a master’s degree and at least 2 years of oncology-related experience
Additional criteria that may strengthen your application:
  • Further professional experience related to the course of studies or completion of an additional qualification in oncology
  • Publications (impact factor > 10)
  • At least 1 year of international oncology experience
Participation
Admission to the certificate is competitive and limited to 30 selected participants.
Who Should Apply
The ideal candidate profile includes:
  • Completed oncology specialisation at least 2 years ago
  • Being engaged in clinical trials or research
  • Fluency in English
  • Age up to 50 years
  • Being based in Europe, the Mediterranean region, or Latin America
Priority will be given to candidates who:
  • Are ESO College members
  • Have attended previous ESO activities
How to Apply
Candidates must complete an online application form and upload the following PDF or JPEG documents:
  • Recommendation letter (on official letterhead, signed)
  • Curriculum Vitae (CV)
  • Copy of medical or science degree (original + certified English translation)
  • Transcript of records (original + certified English translation)
  • Proof of professional experience in oncology (employment/reference letters)
  • Supporting documents for additional qualifications
You will be asked to accept ESO’s Data Protection Statement during the application process.
Selection Process
The current two-step selection method ensures a transparent and unbiased selection of top candidates for participation in this activity:
  • Automated Scoring using a predefined system
  • Committee Evaluation of qualitative answers

The tuition fee is EUR 4.900,00 for all participants.

What’s Included
  • Access to all online modules
  • Registration and accommodation for 3 in-person seminars
  • Participation in all required exams

Travel expenses are not included.

Financial Aid

A CAS Financial Aid Fund is available for candidates unable to cover the full fee. Requests are reviewed case by case.

Cancellation

All cancellation requests must be sent in writing and will be evaluated individually.

Chairs

  • Elias Campo, University of Barcelona, Barcelona, ES
  • Stephan Stilgenbauer, Ulm University Hospital, Ulm, DE
  • Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona, CH

Scientific collaborators

  • Manuela Hoechstetter, Munich Clinic Schwabing, Academic Teaching Hospital Ludwig-Maximilian University (LMU), DE
  • Andrew Lister, St. Bartholomew's Hospital, London, UK

Module Directors

  • Ranjana Advani, Stanford Cancer Institute, Stanford, US
  • Andrew Davies, University of Southampton, Southampton, UK
  • Silvia Montoto, St Bartholomew's Hospital, London, UK
  • Laurie Sehn, British Columbia Cancer Agency, Vancouver, CA
  • Julie M. Vose, University of Nebraska Medical Center, Omaha, US

Project Management and Organisation

  • Sarah Ortelli, ESO, Bellinzona, CH
Haemato-oncology
400
ESO COLLEGE
CREDITS
HYBRID